Neuro-Nutraceuticals and Drug Discovery and Delivery in Alzheimer's Disease
The number of people living with dementia is expected to rise from 55 million in 2019 to 139 million in 2050, according to a report by WHO. Conventional drugs, while providing symptomatic relief, have often fallen short of halting the relentless progression of this neurodegenerative disorder. This new two-volume set represents a collective effort to delve into the potential of nature’s pharmacopei...
The number of people living with dementia is expected to rise from 55 million in 2019 to 139 million in 2050, according to a report by WHO. Conventional drugs, while providing symptomatic relief, have often fallen short of halting the relentless progression of this neurodegenerative disorder. This new two-volume set represents a collective effort to delve into the potential of nature’s pharmacopei...